Skip to main content
. 2020 May 15;4(6):bvaa056. doi: 10.1210/jendso/bvaa056

Table 4.

Distribution (%) of patients with FCS and patients with MCM according to the number of candidate clinical markers presenta

MCM FCS
0 44 (47.3%) 0
1 30 (32.3%) 0
2 15 (16.1%) 1 (3.2%)
3 4 (4.3%) 6 (19.4%)
4 0 4 (12.9%)
5 0 7 (22.6%)
6 0 9 (29.0%)
7 0 4 (12.9%)
Total 93 (100%) 31 (100%)

FCS, familial chylomicronemia syndrome; MCM, multifactorial chylomicronemia.

aAmong patients for which information was available for all candidate clinical markers.